Cited by 196Advanced Glycation End Products researchPotato Plant ResearchGlycosylation and Glycoproteins Research

Intervention against the Maillard reaction in vivo

Monnier, Vincent M.·2003·Archives of Biochemistry and Biophysics

Abstract

The field of Maillard/glycation reactions in vivo has grown enormously during the past 20 years, going from 25 to 500 publications per year. It is now well recognized that many of the "advanced" products form oxidatively or anaerobically and can have deleterious effects on macromolecular and biological function. The feasibility of developing pharmacological agents with beneficial in vivo properties, based on in vitro inhibition of glycation, has been surprisingly successful. This Editorial sets the stage for a series of articles by experts in the field, who have made key contributions to our understanding of the Maillard reaction in vivo.

Integrity signals

Registry

Crossref · 10.1016/j.abb.2003.08.014

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Higher iron intake, especially haem iron, and higher iron status are associated with increased risk of type 2 diabetes, atherosclerosis and coronary heart disease, although the literature is not fully consistent.

    “There is some epidemiological evidence that higher Fe intake, particularly that of haem Fe, and higher Fe status are associated with increased risk of type 2 diabetes, atherosclerosis and CHD (702 -714) , although not all of the literature is consistent.”

The citation lists haven’t been fetched yet

References 162 · Cited by 196

Authors
Monnier, V. M.
Affiliations
Case Western Reserve University (US)
Corresponding author
Monnier, Vincent M.
Venue
Archives of Biochemistry and Biophysics
Publisher
Elsevier BV
Published
2003-11
Volume
419
Issue
1
Pages
1-15
ISSN
0003-9861 (ISSN-L)
OpenAlex
W2049374654
Cited by
196
References
162
Citations by year
2026: 1 · 2025: 2 · 2024: 1 · 2023: 5 · 2022: 4 · 2021: 7 · 2020: 1 · 2019: 5 · 2018: 5 · 2017: 3 · 2016: 7 · 2015: 16 · 2014: 16 · 2013: 10 · 2012: 21
Type
journal article
Language
en
Open access
closed
Locations
  • Archives of Biochemistry and Biophysics (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Eye Institute
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Potato Plant Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
Keywords
Maillard reaction, glycation, advanced glycation end products, glycation inhibitors, pharmacological agents, oxidative stress, macromolecular damage
MeSH terms
Aging, Animals, Diabetes Mellitus, Humans, Inflammation, Kidney Failure, Chronic, Oxidation-Reduction, Maillard Reaction, Glycation End Products, Advanced, Diabetes Complications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review